As FDA Reorganizes, Office Of Chief Counsel Becomes Less Political
Executive Summary
Along with the creation of "directorate" level offices at the commissioner level, FDA also is making a significant change to the chief counsel position following the departure of Ralph Tyler on Aug. 5.
You may also be interested in...
FDA Looks Inside For Chief Counsel, Taps Elizabeth Dickinson
Former FDA attorneys laud her appointment, saying she is highly regarded inside and outside the agency for her intelligence, warmth and expertise on Hatch-Waxman and other key issues.
FDA Reorganization Adds "Directorate" Layer, But Sharpens Agency's Focus
Commissioner Margaret Hamburg’s structural reorganization of FDA leaves the current leadership of the drug and biologic review centers intact but adds a new layer of management and accountability between the medical product center directors and the commissioner’s office.
FDA Reorganization Adds "Directorate" Layer, But Sharpens Agency's Focus
Commissioner Margaret Hamburg’s structural reorganization of FDA leaves the current leadership of the drug and biologic review centers intact but adds a new layer of management and accountability between the medical product center directors and the commissioner’s office.